Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Comera Life Sciences Holdings Inc’s current trading price is -89.74% away from its 52-week high, while its distance from the 52-week low is 1.23%. The stock’s price range over this period has fluctuated between $0.22 and $2.17. The company, operating within the financial sector, had a trading volume of approximately 0.24 million for the day, which was noticeably higher than the average daily share volume of 0.17 million over the last 3 months.
Comera Life Sciences Holdings Inc (CMRA) stock is currently valued at $0.22. During the last session, the stock experienced a remarkable rise, reaching $0.2729 after opening at $0.244. The stock briefly dropped to $0.221 before ultimately closing at $0.24.
In terms of market performance, Comera Life Sciences Holdings Inc had a fairly uneven. The highest value for the stock in the past year was $2.17 on 01/09/23, and the lowest value was recorded at $0.22 on 10/11/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Comera Life Sciences Holdings Inc (CMRA) has experienced a quarterly decline of -63.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.85M and boasts a workforce of 13 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4447, with a change in price of -0.2741. Similarly, Comera Life Sciences Holdings Inc recorded 150,728 in trading volume during the last 100 days, posting a change of -55.17%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CMRA stands at 5.60. Similarly, the long-term debt-to-equity ratio is also 0.00.
CMRA Stock Stochastic Average
Today, Comera Life Sciences Holdings Inc’s raw stochastic average for the past 50 days stands at 1.09%, indicating a decline from the raw stochastic average of the last 20 days, which was 1.10%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 4.36% and 6.01% respectively.
CMRA Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded a decrease of -81.89%. However, over the last six months, the performance has been stronger by -65.32%. The price of CMRA decreased -25.02% over the last 30 days. And in the last five days, it has fallen by -29.41%.